| AD | Alzheimer’s disease |
| AGEs | advanced glycation end products |
| AMD | age-related macular degeneration |
| apoB | apolipoprotein B |
| BDNF | brain-derived neurotrophic factor |
| BMI | body mass index |
| BP | blood pressure |
| BW | body weight |
| CAD | coronary artery disease |
| CHD | coronary heart disease |
| CI | confidence interval |
| CNS | central nervous system |
| CRP | C-reactive protein |
| CVD | cardiovascular diseases |
| EA | ellagic acid |
| EGCG | (−)-epigallocatechin-3-gallate |
| ER | estrogen receptor |
| ETs | ellagitannins |
| FMD | flow-mediated dilation |
| GLUTs | glucose transporters |
| GM | gut microbiota |
| HbA1c | hemoglobin A1c |
| HDL-C | high density lipoprotein-cholesterol |
| HOMA-IR | Homeostatic Model Assessment—Insulin Resistance |
| HR | hazard ratio |
| IHD | ischemic heart disease |
| IL-6 | interleukin 6 |
| KBs | ketone bodies |
| KDs | ketogenic diets |
| LDL-C | low density lipoprotein-cholesterol |
| MDD | major depressive disorder |
| MD | Mediterranean diet |
| MS | metabolic syndrome |
| MUFAs | monounsaturated fatty acids |
| NO | nitric oxide |
| OR | odds ratio |
| PD | Parkinson’s disease |
| PTS | pterostilbene |
| PUFAs | polyunsaturated fatty acids |
| RCT | randomized controlled trial |
| ROS | reactive oxygen species |
| RR | relative risk |
| T-C | total cholesterol |
| T2DM | type 2 diabetes mellitus |
| TG | triglycerides |
| TNF-α | tumor necrosis factor-α |
| VLDL-C | very-low-density lipoprotein cholesterol |
| Wc | waist circumference |